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Abstract
Introduction: Rational use of corticosteroids is very important in the long term for improving patient safety. The main 
objective of the study was to analyze the prescribing patterns of steroids in a district general hospital, Amravati.
Materials and methods: A prospective observational study was carried out over a period of six months in a district 
general hospital. All patients receiving any category of steroid therapy were enrolled, and the prescribing tapering pat-
terns of steroids were reviewed. The demographic data, disease data and data on the utilization of various steroids were 
analyzed, and the knowledge of the patients was assessed by using a Michigan questionnaire.
Results and discussion: 179 patients were recruited for the study. Steroids were prescribed for various (29.6%) respi-
ratory conditions, (10.1%) CVS diseases, (11.7%) CNS, (1.6%) in hepatic disorders, (1.1%) musculoskeletal disorders, 
(3.4%) skeletal disorders, (0.6%) renal impairments, (3.9%) GI disorders, (19.0%) skin diseases and (19.0%) other 
diseases. The utilization of steroid dexamethasone was the most commonly prescribed to 111 patients (63.8%) followed 
by hydrocortisone (57 patients, 32.8%) and prednisolone (6 patients, 3.4 %). Dexamethasone was most commonly 
associated with adverse effects (1.8% of such as headaches, abdominal pains, and rashes), followed by prednisolone 
(0.8% of such as facial swelling), clobetasol (0.4%) and fluticasone (0.4 %).
Conclusions: Very little variation was found in the prescription pattern amongst the healthcare professionals. Most of 
the drugs were prescribed rationally; the significance of the study is to improve the patient safety in the long-term use of 
steroid therapy by observing the prescribing patterns as irrational use of steroids can increase the risk of adverse effects.
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Introduction
Corticosteroids are widely accepted by health care pro-
fessional for their anti-inflammatory qualities and some 
profound clinical results. Corticosteroids are drugs with 
immunosuppressive and anti-inflammatory properties. 
However, their side effect profile makes careful con-
sideration before use and regular review paramount 
(Dhandapani et al. 2015). In the field of respirology, sys-
temic corticosteroids are used for the treatment of acute 
exacerbations of chronic obstructive pulmonary disease 
(COPD) and severe, uncontrolled asthma, as well as for 
inflammatory parenchymal lung diseases, such as hyper-
sensitivity pneumonitis and immune mediated vasculitis 
(Liu et al. 2013). Oral corticosteroids become important 
part of therapy regimens for a diverse variety of conditi-
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ons. Despite their efficacy, they are associated with a wide 
variety of adverse events (Manson et al. 2009). There has 
been an increasing concern regarding the safety of corti-
costeroids, as a large number of patients are prescribed 
these drugs for a long-term prophylactic treatment. The 
dose of corticosteroids that is prescribed, dispensed and 
applied must be carefully considered as too little steroid 
can show poor response whereas excess application can 
increase the risk of adverse reaction. For this, rational 
use is necessary to minimize both systemic and cutane-
ous side effects (Ference and Last 2009). The corticoids 
have widespread actions. They maintain fluid-electroly-
te, cardiovascular and energy substrate homeostasis and 
functional status of skeletal muscles and nervous system. 
They prepare the body to withstand effects of all kinds of 
noxious stimuli and stress (Sharma and Ksharma 2017).
In India, most of these medications, especially topical 
corticosteroids, are sold without any prescription and a 
patient can easily obtain these medications from a local 
pharmacy. As per the information available on the Central 
Drugs Standard Control Organization (CDSCO) website, 
their off label use is more commonly practiced in India. 
Also, their inappropriate use in the treatment of various 
dermatological disorders, like acne, bacterial or fungal 
infections, and rash when prescribed by non-registered 
practitioners or on the advice of a pharmacist. This will 
increase the adverse effects and can lead to dependence 
on these medications (Ambika et al. 2014, Saraswat et al. 
2011). Many researchers has been reported the use of cor-
ticosteroid was irrational due to as there were a number of 
interactions observed mostly prescribed in geriatric patient 
(Dabral and Devesh 2018, Mirshad et al. 2017, Nerurkar et 
al. 2016, Stern 1996). Prescriptions need to be audited pe-
riodically to enhance the therapeutic effectiveness, to min-
imize the adverse effects, to provide critical feedback to 
prescribers and to analyse the execution of medical treat-
ment standards. Data evaluation is the most crucial step in 
the drug utilization studies (Kumar et al. 2011). Period-
ic monitoring of the drug utilization pattern is one of the 
methods to analyze the rationality of the drug and has been 
an effective tool to constitute guidelines for improving the 
utilization pattern (Sweileh 2006). This will not only con-
stitute a rational therapy, but also lead to economic benefits 
and easy identification of the problem related to drug use, 
like poly pharmacy, drug interactions and adverse reac-
tions (Aryal et al. 2017). The main objective of the study 
was to analyze the prescribing pattern of corticosteroids 
among the patients from general medicine and dermatol-
ogy department of a district general hospital in Amravati.
Materials and methods
This was a qualitative study during which prospective ob-
servational, non-interventional interviews were conduc-
ted for six months to gather details about how patients 
perceived any category of steroid therapy. Research ethics 
approval was received from Research Ethics Committees 
of the participating hospital (REC/17/GCOPA/3) at go-
vernment district general hospital, Amravati and Pharm.D 
pharmacy practice center of Government College of Phar-
macy Amravati Maharashtra. Each patient was informed 
about the purpose of the study and written consent was 
obtained prior to their participation in the study. An infor-
med consent form to participate in research of samples, 
ensure the confidentiality of the information received and 
used only for research purposes which were fully met.
Patients of either sex of various age groups who re-
ceived any category of steroid therapy in both the depart-
ments, either inpatient or outpatient settings, were includ-
ed for this study. Eligible patients, who were prescribed 
steroids medications to manage acute or chronic dis-
ease(s), had been admitted to a clinical area and presented 
a past history of steroid intake and those who had been 
reported of abusing steroids included. The operationally 
some important terms use like steroid abuse and it is de-
fined as inappropriate use of steroids for a period of more 
than one year for the study purpose. Patients visiting the 
outpatient department of general hospital medicine ward, 
patients not willing to sign a consent, unconscious pa-
tients were excluded.
Sample size was 179 patients of various departments 
over a period of 6 months from October 2017 to March 
2018 in a district general hospital, Amravati. Interview 
questions and prompts were designed to elicit partici-
pants’ views about the use of corticosteroids. Observa-
tional notes and reflexive note-taking were conducted 
throughout the study. Patient data relevant to the study 
was collected from treatment charts/case sheets, laborato-
ry reports and patients’ or patients’ caregivers’ interviews 
by using a patient data collection form. It included the pa-
tient demographics data and occupation, the dosage regi-
men, duration of hospitalization, laboratory data, adverse 
drug reaction and other relevant information. The data 
was collected on a prevalidated case record proforma. 
The observational results were screened for various pa-
rameters viz; gender and age wise distribution, taking into 
account rationality, concomitant and comorbid diseases.
Practioners’ opinions of effective use of steroids were 
analyzed using some guidelines. The samples of tran-
scripts were checked by co-researchers to ensure appro-
priate and consistent interpretation. The data generated in 
this study was analyzed for ADR, documentation and re-
porting of ADRs, appropriateness of drug, dose, frequen-
cy and duration. The data were summarized by routine 
descriptive statistics, namely, mean and standard devia-
tion, correlation for numerical variables, counts and per-
centages for categorical variables.
Results
A total number of 179 patients meeting the inclusion cri-
teria were enrolled for present study. The study took place 
between October 2017 and March 2018. The detailed de-
mographic data is demonstrated in Table 1. The subjects 
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were categorized according to gender and out of 179 sub-
jects 94 (52.5%) were males and 85 (47.5%) were females. 
According to age group distribution, 17 subjects were in 
the age group of <20, 19 subjects were in the age group of 
21–30 years, 30 subjects were in the age group of 31–40 
years, 38 subjects were in the age group of 41–50, 24 sub-
jects were in the age group of 51–60 and 51 subjects were 
in the age group above 60 years, the mean age of the popu-
lation was 49.7±6.8 (Mean±SD) and the range of ages was 
between <20–60> years old. The mean ages of the male 
and female patients were 48.0±6.0 and 51.5±7.7 years old, 
respectively. Median of different age groups and frequency 
of patients was not correlated based on results (r2=0.73). 
Social history of patients included information regarding 
social habits, such as smoking and alcoholism. The dis-
tribution of social habits in the patients who participated 
in the study were 59 smokers and 44 alcoholics (Table 1).
The routes of administration of corticosteroid were intra-
venous (87.1%), topical (9.3%) and oral (3.6%). The system 
associated with disease is given in Fig 1. The data collected 
comprised of 53 (29.6%) patients of respiratory condition, 
18 (10.1%) patients of cardiovascular system diseases, 21 
(11.7%) patients of central nervous system, 3 (1.6%) with 
hepatic disorder, 2 (1.1%) patients with musculoskele-
tal disorders, 6 (3.4%) patients with skeletal disorders, 1 
(0.6%) patients with renal impairments, 7 (3.9%) patients 
with gastro intestinal disorders, 34 (19.0%) patients with 
skin diseases and 34 (19.0%) patients with other diseases.
Nine basic dermatological disorders were observed in 
which corticosteroids were used during the study (Fig 2). 
The most common indications of prescribing corticoster-
oids were dermatitis (19%), eczema (16%), lichen planus 
(16%) and urticaria (16%), erythema multiforme (12%), 
psoriasis (6%), vitiligo (6%) and leprosy (6%), and mac-
ulopopular rashes (3%).
From the data, after the first most common group of 
diseases – the respiratory system pathologies, 34 patients 
of various skin diseases were observed and so present-
ed the structure of dermatological diseases. Respiratory 
system pathologies associated with steroids use com-
prised of 53 (29.6%) patients. The different respiratory 
system pathologies treated by corticosteroids demon-
strated chronic obstructive pulmonary disease (COPD) 
(24 patients, 45.3%) lower pulmonary tract infection (12 
patients, 22.6%), bronchial asthma (6 patients, 11.3%), 3 
(5.7%). COPD was the diagnosis for which most of the 
corticosteroid were prescribed.
The results of steroid use in general medicine and der-
matology are given in Table 2. The total of 225 steroid 
Table 1. Basic demographic data (n = 179).













Figure 1. Systems associated with steroids use and their per-
centage.
Table 2. Steroid used in general medicine and dermatology.
Steroids General Medicine Percentage (%) Dermatology Percentage (%) Total No of Patients Percentage (%)
Betamethasone 0 0 1 2.0 1 0.4
Clobetasol 0 0 14 27.5 14 6.2
Dexamethasone 111 63.8 28 54.9 139 61.8
Fluticasone 0 0 4 7.8 4 1.8
Hydrocortisone 57 32.8 0 0 57 25.3
Prednisolone 6 3.4 2 3.9 8 3.6
Triamcinolone 0 0 2 3.9 2 0.9
Total 174 100 51 100 225 100
Figure 2. Dermatological disorder associated with steroid use.
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drugs were prescribed in 179 patients during the study 
period, from which 174 drugs – in the general medicine 
ward: dexamethasone was given to 111 (63.8%) patients, 
hydrocortisone was given to 57 (32.8%) patients and 
prednisolone was given to 6 (3.4%) patients.
In the dermatology department, out of 51 drugs, beta-
methasone was given to 1 (2.0%) patient, clobetasol was 
given to 14 (27.5%) patients, dexamethasone was given 
to 28 (54.9%) patients, fluticasone was given to 4 (7.8%) 
patients, prednisolone was given to 2 (3.9%) patients, and 
triamcinolone was also given to 2 (3.9%) patients. Dex-
amethasone (as a long-acting drug) was prescibed most 
frequently, while hydrocortisone was used as a short act-
ing and prednisolone – as an intermediate acting corticos-
teroids (Fig. 3).
The rationality of steroids was measured on the ba-
sis of prescriber-related factors, steroid abuse and dose 
tapering. The prescriber-related factors, steroid abuse, 
dose tapering, ADRs due to corticosteroid use are given 
in Table 3. Maximum corticosteroids were prescribed by 
the generic name from the hospital pharmacy (96.8%) as 
compared to the brand name from outside pharmacies 
(3.1%). Out of 179 patients, 20 patients were found to 
have a past medication history of steroids. Out of 20 pa-
tients, 5 patients were found abusing steroids and 15 were 
not abusing steroids. Total 8 steroid-related adverse drug 
reactions were observed in the present study.
Types of adverse side effects of corticosteroids are pre-
sented in Table 4. Dexamethasone was most commonly as-
sociated with adverse effects (1.8% of all the prescriptions), 
such as headaches, abdominal pains, rashes, followed by 
prednisolone (0.8%) leading to such adverse effects as fa-
cial swelling, then clobetasol (0.4%) and fluticasone (0.4%).
Some factors were found to deviate from rationality, 
like inappropriate drug history, drug dose not mentioned, 
frequency not mentioned, wrong administration, dose 
omission, illegible hand writing, lack of dose tapering 
and steroid abuse of the patients 22 (12.3%). The strength 
of the active constituent 2 (2.1%), frequency of adminis-
tration 2 (2.1%), wrong administration 10 (45.5%), dose 
omission 5 (22.7%), illegible hand writing 14 (63.6%), 
lack of dose tapering 6 (27.3%) and steroid abuse 3 
(13.6%) were not specified for the majority of the pre-
scriptions. But the frequency of their occurrence was sta-
tistically significantly negligible (P<0.05).
Discussion
Corticosteroids are commonly used for the treatment of 
many inflammatory and autoimmune conditions which 
requires time to time reviewing of the prescription. The 
rational prescribing of the drugs is essential to increase 
the therapeutic efficacy and decrease the adverse effects 
of the drugs. In addition, the study tried to describe the 
common diseases encountered and the drugs common-
ly prescribed in general medicine and dermatology. The 
commonly used steroids without consulting a derma-
tologist and their health consequences were addressed 
through the qualitative method. To ensure safety, effec-
tiveness and well balanced therapeutic management of 
corticosteroids, both patients and prescribers should be 
more aware of the appropriate dose, dosage regimen, 
drug-drug interactions, ADRs and overall guidelines for 
prescribing corticosteroids. Considering the prevalence 
of use of corticosteroids and severity of the problems in 
patients, investigation of steroid utilization patterns help 
to evaluate and analyze the reasons for their increased and 
inappropriate use in population. The study will be of use 
to improve the patient safety by observing the prescribing 
patterns as irrational use of steroids. Several studies have 
addressed the issue of steroidal drug prescribing patterns. 
Some of these have indicated inappropriate utilization or 
over-utilization of potent, topical corticosteroids.
The total of 179 patients meeting the inclusion criteria 
were enrolled into the present study. The study took place 
between October 2017 and March 2018. Participants’ de-
Table 3. Prescriber-related factors, steroid abuse, dose tapering 
in corticosteroid use.
Index Index research group
Patients with the Index
N %
Generic Name 225 218 96.9
Frequency 
Mentioned 225 223 99.1
Dose mentioned 225 223 99.1
Steroids abuse 20 5 25.0
Gradual withdrawal 225 11 4.9
Adverse drug effects 225 8 3.6
Figure 3. Steroid classification based on duration of action.
Table 4. Types of Adverse Drug Side Effects by Use of Corticosteroids.
Index DrugDexamethasone Prednisolone Clobetasol Fluticasone
Total drug prescriptions 139 8 14 4
ADR Headache, Abdominal pain, Rashes Facial swelling Pigmentation on skin Redness of skin
Number of ADR 4 2 1 1
Percentage 2.9 25.0 7.1 25.0
Research Results in Pharmacology 5(2): 57–64 61
mographic information includes 94 (53%) males and 85 
(47%) females. P-value is 0.002518, which is less than 
0.05, hence males were found significantly different when 
using corticosteroids as compared to females. The major-
ity of the study subjects who participated in this study 
belonged to the age group of >60 years, followed by those 
of 41–50 years of age and 51–60 years old. It seems that 
geriatric patients are prone to a higher risk of medica-
tion-related problems because of the higher numbers of 
prescribed medications, intensity of the work environ-
ment, presence of critical illness, and increased use of 
high risk medications. Similarly, more males were found 
to be using corticosteroids as compared to females. Out 
of 179 patients, 103 patients were associated with social 
habits, such as smoking and alcoholism, which means the 
reported information was affected by these factors. The 
difference in patients between these two groups (smok-
ers (59), alcoholics (44) and normal (76)) was statistically 
significant (p<0.05). The prevalence of prescription users 
increased substantially with age and one of factors could 
be illiteracy. Thus, persons aged 40–60 were more than 
4 times as likely and persons aged above 60 were more 
than 3 times as likely to receive treatment than those aged 
under 19 years old. This shows that with advanced age, 
the number of diseases increases, due to which the use 
of corticosteroids increases. During the study period, 225 
steroid drugs were prescribed to 179 patients who met the 
criteria considering the prevalent use of corticosteroids 
for treatment of any types of diseases. Therefore, diseas-
es classified were based on human system-related issues 
viz; respiratory condition, CVS diseases, CNS diseases, 
hepatic disorders, musculoskeletal disorders, skeletal dis-
orders, renal impairments, GI disorders and skin diseas-
es. From among the three routes of administration related 
to the above diseases for the use of corticosteroids, none 
was specified for the majority of patients. But for the ma-
jority of inpatients’ prescriptions, a route of administra-
tion and duration of application were specified and the 
mean hospital stay of the patients was 18 days, while the 
longest inpatient stays were 31 days for COPD patients. 
The most preferred route of administration of corticoster-
oid was intravenous (87.1%) followed by topical (9.3%) 
and oral (3.6%). Where injection dosage forms that were 
prescribed along with the topical preparation constituted 
36%, oral 2% and combination of topical, oral and injec-
tion dosage forms accounted for 5%. Based on disease 
conditions, the various routes of administration were ap-
plied to the exposed steroids, and in some instances, only 
one route of administration was applied to the patients; 
hence this can be due to the difference in the inclusion cri-
teria of the study. A similar study was conducted for eval-
uation of corticosteroid utilization patterns in a tertiary 
care hospital (Dabral and Devesh 2018). These all data 
suggested that among various dosage forms of steroids 
use, injection was most widely/frequently used, followed 
by topical and oral forms. The major clinical complaints 
of the patients admitted in general medicine departments 
were related to Respiratory tract (29.6%), followed by 
dermatological complaints (19%), renal impairments 
(4%) and musculoskeletal disorders (3%), which was 
similar to the study done in a pulmonary department (Var-
key and Sen 2015). The most common indications for 
prescribing corticosteroid were dermatitis (19%), eczema 
(16%), lichen planus and urticaria (16% each), erythema 
multiforme (12%), psoriasis and vitiligo (6%), macu-
lopopular rashes (3%) and others (6%). The total of 225 
steroid drugs were prescribed to 179 patients during the 
study period. The study was conducted in general ward 
and dermatological department of the hospital. In relation 
to this, dermatological diseases and diseases of the res-
piratory systems were easy to facilitate patient tracking 
for compile structure and related information. Consider-
ing the duration of therapy, investigation requires track-
ing patients associated with short and long courses of 
treatment to find out efficacy of steroids. For inpatients’ 
prescription, the duration of application was specified at 
18 days. Systemically dexamethasone was commonly 
prescribed to most of the patients, which may be due to its 
potency and longer duration of action. In the present study 
out of 21 topical steroid, ultra high-potency corticoster-
oids were prescribed more frequently (66.26% of cases), 
followed by moderate-potency (13.9%) and high-poten-
cy (27.9%). In the study, long acting corticosteroids used 
were dexamethasone and betamethasone. Non-infectious 
skin diseases, like dermatitis, topped by 19%, followed by 
Eczema (16%), lichen planus and urticaria (16% each).
This disease pattern is comparable to the study conducted 
in Karaikal, which showed similar reports (Divyashanthi 
et al. 2014, Wahane et al. 2016). This shows that the inci-
dence of the skin disease depends mostly on a geograph-
ical location, genetic makeup as well as environmental 
factors. In spite of the fact that these drugs can cause seri-
ous adverse effects, these are easily available and are sold 
without prescription, and also there is very little aware-
ness about the potential side effects in the general public. 
In the general medicine ward, dexamethasone was given 
to 63.8% of patients, followed by hydrocortisone (32.8% 
of patients) and prednisolone (3.4% of patients). In der-
matology department, out of 51 drugs, betamethasone 
was given to 1.9% of patients. Dexamethasone was pre-
scribed most frequently, while hydrocortisone was used 
as a short acting and prednisolone as an intermediately 
acting corticosteroid. The study included only rationality 
of steroids use in population to find out their safety of 
use. From the data, after the first most common group of 
diseases – the respiratory system pathologies, 34 patients 
of various skin diseases were observed and so presented 
the structure of dermatological diseases in the manuscript. 
Respiratory system pathologies associated with steroids 
use comprised of 53 (29.6%) patients. The different res-
piratory system pathologies treated by corticosteroids 
were bronchial asthma (6 patients, 11.3%), laryngeal ede-
ma (2 patients, 3.83%), allergic, obstructive syndrome (6 
patients, 11.3%), lower pulmonary tract infections (12 
patients, 22.6%), chronic obstructive pulmonary disease 
(COPD) (24 patients, 45.3%), pneumonia (3 patients, 
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5.7%). COPD was the diagnosis for which most of the 
corticosteroids were prescribed.
The rationality of steroids is measured on the basis of 
prescriber-related factors, steroid abuse and dose taper-
ing. Like with alcohol or street drugs, the common signs 
of addiction may develop with the use of steroids. These 
include drug cravings, requiring more drugs to provide the 
same effect, and withdrawal symptoms if someone stops 
taking the drug. This condition is referred to as steroids 
abuse. The steroid abuse factor was defined as a factor 
influencing the rational use of steroids through the admin-
istrator that includes dose omission and withdrawal. Ac-
cording to the National Institute of Drug Abuse, the use 
of steroids continues to be a significant problem in the ad-
olescent population. They published data on steroid abuse 
factor associated with steroids. Maximum corticosteroids 
were prescribed by generic names from hospital pharma-
cies (96.8%) as compared to brand names from outside 
pharmacies (3.2%). Out of 179 patients, 20 patients were 
found to have a past medication history of steroids. Out of 
20 patients, 5 patients were found abusing steroids and 15 
were not abusing steroids. So there is a rational use steroid 
according to the steroid abuse factor. In the data collected, 
dose tapering was done for 11 drugs, and tapering was not 
done for 214 drugs. Ultra high-potency corticosteroids 
were clobetasol used in dermatitis, lichen planus, psoria-
sis and eczema. High-potency corticosteroids, like triam-
cinolone and betamethasone, were prescribed for vitiligo 
maculopopular rashes. Moderate-potency corticosteroids, 
such as fluticasone, were prescribed for vitiligo and ec-
zema. There is no use of low-potency corticosteroids. An 
ultra-high-potency drug causes serious adverse effect, 
and these drugs are easily available and are sold without 
prescription, and also there is very little awareness about 
their potential side effects in the general public. Using ge-
neric names usually provides flexibility to the dispensing 
pharmacist, and generic drugs are less expensive than the 
branded drugs. There is rational use of steroids by pre-
scriber-related factor. The dose was tapper, it require so 
there were in rational use of steroid by this factor. It was 
found out that right steroids were prescribed for right in-
dications to right patients. This assures that rationality is 
genuinely followed while prescribing. However, some 
factors were found that deviate from rationality, such as 
inappropriate drug history, not mentioned drug dose, not 
mentioned frequency, wrong administration, dose omis-
sion, illegible hand writing, lack of dose tapering and ster-
oid abuse. Not specifying these factors can lead to under 
usage of the medication and can further lead to sub ther-
apeutic outcome; at the same time excessive usage can 
lead to unwanted effects (Ference and Last 2009, Sweileh 
2006). Most drugs were prescribed in generic names, and 
doses were mentioned with frequency, but no fixed dose 
combinations of steroids were used. Appropriate dose ta-
pering was done in required patients. Few patients were 
found to be abusing steroids due to lack of knowledge 
about the medication. Clear instructions should be pro-
vided so that the patients are aware of how much steroid 
should be used and how long it should be used (Oshikoya 
et al. 2008). Also, generic names for most of the drugs 
were not mentioned at all. Using generic names usual-
ly provides flexibility to the dispensing pharmacist and 
generic drugs are less expensive than the branded drugs.
Total 8 steroid-related adverse drug reactions were 
observed in the present study. Dexamethasone was most 
commonly associated with adverse effect (1.8%), such as 
headaches, abdominal pains, rashes, followed by predni-
solone (0.8%) with side effects such as facial swelling, 
then clobetasol (0.4%) and fluticasone (0.4%). There 
were no appropriate guidelines, and drug interaction re-
porting is emerging scope of pharmacy should be consid-
erable (Mukherjee et al. 2016). Most of the drugs were 
prescribed for right indications to right patients; however, 
some factors, such as in appropriate drug history, improp-
er mentioning of dose and frequency, wrong administra-
tion time, dose omission, improper dose tapering were 
found to be deviating away from the rationality.
The use of steroids is seen more frequently in elderly 
patients, which suggests that elderly patients should be 
monitored more closely while treating them with steroids. 
To ensure safety, effectiveness and well balanced thera-
peutic management of corticosteroids, both patients and 
prescribers should be more aware of the appropriate dose, 
dosage regimen, drug-drug interactions, ADRs and overall 
guidelines for prescribing corticosteroids. Hence, a clini-
cal pharmacist can perform a potential role in health care 
system in assisting a physician in altering the number of 
medications taken, the number of doses taken, improving 
the patient’s medication adherence, preventing the adverse 
drug reactions, drug-drug interactions, in counseling pa-
tient to improve the health-related quality of life and in 
decreasing the health care cost to the patient. Moreover, 
the lack of medical education from the health care pro-
fessionals to the patients enforces the conduction of the 
study. It has therefore become very important to monitor 
and evaluate the prescribing patterns of corticosteroids.
A key strength of this study is its novel approach taken 
in hospitals to the obtained results which may have im-
plications for both pharmacy students and medical prac-
titioners by increasing their awareness of patients when 
using steroids. Interestingly, overtime and perhaps with 
changing demographics and patients’ expectations of 
healthcare professionals, researchers have found that an 
increasing proportion of patients prefer sharing decision 
roles with clinicians. Potential limitation of this study was 
the limited samples due to a short study period. The data 
were collected only from October 2017 to March 2018. 
Very few patients were available in the dermatology de-
partment, as most of the patients did not require hospital 
admission. The regional language barrier during commu-
nication with the patients when the supporting staff were 
not available in the ward was another limitation.
Easy availability of the steroids in pharmacies, espe-
cially, topical steroids, is one of the major factors respon-
sible for their irrational use. Irrational use/abuse of topical 
or systemic steroids may lead to severe ADRs and affect 
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the quality of life of patients. Hence, establishing stand-
ard guidelines for prescribers for treating any acute and 
chronic diseases where steroids are necessary is highly 
warranted. Also, there is an increasing need to strengthen 
the laws regarding the procurement, storing, dispensing 
of steroidal medicines at the retail pharmacies.
Conclusion
There was not much variation found in the prescription 
patterns amongst the healthcare professionals. Although 
most of the drugs were prescribed rationally, involvement 
of a clinical pharmacist in patient care can help rational 
prescribing along with prevention and early detection of 
ADRs, which can directly promote drug safety and im-
prove patients’ outcomes.
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